Articles

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Sweden
Hematology/Immunology Section, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Sweden;Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Sweden
Hematology/Immunology Section, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Sweden;Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden
Department of Hematology, Karolinska University Hospital and Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Sweden
Therapeutic Immunology Unit, Department of Laboratory Medicine, Karolinska Institutet, Sweden;Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Sweden
Vol. 99 No. 2 (2014): February, 2014 https://doi.org/10.3324/haematol.2013.087338